CD40LG and COVID-19: This study compared the immune responses of mild COVID-19 cases from the United Kingdom and Uganda, focusing on the longitudinal dynamics of key immunoglobulins, including spike IgG, nucleocapsid IgG, spike IgM, nucleocapsid IgM, and receptor-binding domain (RBD) IgM.